Updated:
by
Sanjiv Lakhanpal, MD, FACS
Medically reviewed by Sanjiv Lakhanpal, MD, FACS
You have probably heard of weight loss drugs such as Ozempic, Wegovy, or Mounjaro. These are brand names for a group of medicines called GLP-1 receptor agonists. They were first developed to treat type 2 diabetes, but millions of people now use them for weight loss, too. In fact, they are some of the most prescribed drugs in the country right now.
These medications do much more than just lower blood sugar and reduce appetite. They also affect your blood vessels. Most of the research so far has focused on the heart and arteries, but what about your veins? If you have varicose veins, spider veins, leg pain, or leg swelling, this is information you need to know.
In this blog, Sanjiv Lakhanpal, MD, FACS, Founder, President, and CEO of Center for Vein Restoration (CVR), breaks it down in plain language so you can have a more informed conversation with your primary care doctor or vein specialist about using these powerful medications to support health.
Have questions about GLP-1 medications and your vein health? The expert physicians at Center for Vein Restoration have helped thousands of patients navigate the connection between weight loss and vein disease. With more than 130 clinic locations nationwide, trusted care is closer than you think. Find a location near you.
GLP-1 stands for glucagon-like peptide-1. Your body naturally makes this hormone in your gut after you eat. It signals your pancreas to release insulin, tells your brain you are full, and slows down digestion. GLP-1 medications work by imitating this hormone. According to Mayo Clinic, these drugs are among the most effective tools available today for managing both blood sugar and body weight in adults.
The most common GLP-1 drugs you may have heard of include:
These medications help people lose significant weight and reduce the risk of serious heart problems.
Here is something many people do not realize: GLP-1 receptors are not only in your pancreas. They are also found in the walls of your blood vessels, your heart muscle, and your immune cells.
That means these medications have a direct effect on your entire vascular system, not just your blood sugar. According to research reviewed by the National Library of Medicine, GLP-1 medications can:
These are all good things for your circulatory system, including your veins.
A major clinical trial called the SELECT trial, published in the New England Journal of Medicine, followed over 17,000 people who were overweight or obese and had existing heart disease. Those who took weekly semaglutide had a 20 percent lower risk of serious heart events like heart attacks and strokes compared to those who did not. This was a landmark study that showed a weight-loss drug could protect the heart even in people who did not have diabetes.
According to Cleveland Clinic, cardiovascular disease remains the leading cause of death in the United States. It is the number one killer of women overall, claiming more lives each year than all cancers combined. This kind of risk reduction is a very big deal for the millions of Americans who are overweight and already living with heart disease.
A subsequent analysis of SELECT trial data presented at the 2025 European Congress on Obesity found that the heart benefits appeared within just a few weeks of starting the medication — and were not entirely explained by weight loss alone. Something else was happening at the level of the blood vessels themselves.
Healthy veins rely on tiny one-way valves to push blood upward from the legs back to the heart. When those valves weaken or fail, blood pools in the legs — a condition called venous insufficiency. Over time, that pooling puts sustained pressure on the vein walls and surrounding tissue, producing the symptoms most people recognize: twisted, rope-like varicose veins, smaller spider veins, persistent leg swelling, aching, skin discoloration, and in advanced cases, open sores called venous ulcers.
Carrying extra weight, particularly around the abdomen, is one of the most significant modifiable risk factors for vein disease. Excess abdominal weight increases pressure in the pelvis and abdomen, making it harder for blood in the leg veins to return to the heart. Over time, that sustained pressure accelerates valve damage and worsens venous insufficiency. For patients already predisposed to vein disease through family history or age, obesity compounds that risk considerably.
When people lose a significant amount of weight with GLP-1 medications, it reduces the pressure on their leg veins. This can:
In many ways, GLP-1 therapy is genuinely good for people with vein disease. Cleveland Clinic's vascular disease resources confirm that weight management is one of the top lifestyle strategies for managing chronic venous insufficiency.
Even though losing weight is generally good for your veins, the rapid weight loss that often comes with GLP-1 medications can cause some unexpected vein issues your doctor needs to know about.
1. Your Varicose Veins May Suddenly Look Worse
As you lose weight, the layer of fat under your skin gets thinner. Varicose veins that were hidden beneath that fat become much more visible. Your legs might look like the vein disease got worse when really the veins were already there — just masked by surrounding fat tissue.
This is not something to panic about, but it can be alarming if you are not prepared for it. If your varicose veins suddenly look more prominent after starting a GLP-1 medication, talk to your vein doctor before assuming the worst. They can do a simple ultrasound scan to check what is really going on.
2. Losing Muscle Can Hurt Your Veins
GLP-1 medications help people lose fat, but they can also cause loss of muscle mass, especially without strength training. This matters more than most people realize.
Your calf muscles act like a pump that squeezes blood back up through your veins toward your heart every time you walk or move. If you lose calf muscle, the pump gets weaker, and blood can pool more easily in your legs, worsening vein disease and venous insufficiency.
The solution? Start resistance training — lifting weights, using resistance bands, or doing bodyweight exercises — as soon as you begin GLP-1 therapy. This is not just about staying strong. It is a genuine vein health strategy. UCSF Health recommends regular leg exercises as part of managing venous disease.
3. Dehydration Is a Hidden Risk
GLP-1 medications often cause nausea and reduce your appetite for both food and fluids, especially early on. If you are not drinking enough water, your blood can thicken, making it more likely to clot.
Blood clots in the veins, known as deep vein thrombosis (DVT), are serious and potentially life-threatening if a clot breaks off and travels to the lungs, in a condition called pulmonary embolism (PE). This risk is highest during the first few months of GLP-1 therapy when doses are being increased. If you are taking GLP-1 medications, make a conscious effort to drink water throughout the day, even when you do not feel thirsty.
This is an important question, and the research presents a nuanced picture.
A large 2025 study published in Blood Advances examined more than 540,000 patients with type 2 diabetes across 21 countries and found that those taking GLP-1 medications had about a 20 percent lower risk of venous blood clots compared to those taking a different class of diabetes drug. Notably, that protective effect held even among patients who were not obese — suggesting the medication itself may be doing more than simply reducing weight.
A separate 2025 systematic review and meta-analysis published in the Journal of Thrombosis and Haemostasis analyzed 27 clinical trials involving more than 84,000 patients. They found that people taking GLP-1 medications had a 40 percent lower risk of pulmonary embolism (PE), the potentially fatal condition that occurs when a blood clot travels to the lungs. That specific finding was statistically significant. The same analysis did not find a significant reduction in overall blood clot or DVT risk, which is why your vein doctor's full picture of your health still matters when assessing your individual risk.
However, a 2025 meta-analysis published in the Journal of the American Heart Association found that people who had been taking GLP-1 medications for 78 weeks or longer (roughly a year and a half) had a significantly higher risk of developing a DVT compared to non-users. This finding was not seen in people who used GLP-1 medications for shorter periods and has not been consistently confirmed across other studies. It is an important reason to be upfront with your vein doctor about how long you have been on a GLP-1 medication, particularly if you are also managing existing vein disease or other DVT risk factors.
The bottom line: the research on GLP-1 medications and blood clot risk is genuinely mixed. PE risk appears lower in some analyses, while long-term use may raise DVT risk. Every patient's situation is different, which is why discussing your full vein history with a specialist matters.
Do you have questions about GLP-1 use, weight loss, and vein health? CVR is here to help. 📞 To speak to a Patient Services Representative, call 240-249-8250 📅Book an appointment at CVR online
No. Weight loss can reduce symptoms and slow the progression of vein disease, but it cannot repair damaged valves. The structural valve failure that causes varicose veins, spider veins, and chronic venous insufficiency does not reverse with weight loss alone, and GLP-1 medications are not a substitute for vein treatment.
If you are experiencing visible varicosities, leg heaviness, swelling, cramping, or restless legs, a consultation with a CVR vein specialist is the appropriate next step. Modern vein treatments are minimally invasive, performed as an outpatient in a comfortable office setting, and require little to no downtime. Procedures include:
Research published by CVR's own physicians Dr.Sanjiv Lakhanpal, Dr. Zoe Deol and Dr. Peter J. Pappas in the Journal of Vascular Surgery: Venous and Lymphatic Disorders found that treatment outcomes for chronic venous disease improve as BMI decreases, and that higher BMI is independently associated with poorer results after venous procedures.
In practical terms, this means that losing weight with a GLP-1 medication before or alongside vein treatment is not just good for your overall health; it may directly improve what your vein specialist can achieve for you. Reducing pressure on your venous system before treatment gives the treatment the best possible environment in which to work.
If you are taking a GLP-1 medication and notice any of the following, contact CVR to schedule an evaluation:
Vein disease is progressive, and it tends to worsen over time without treatment. The earlier you see a CVR vein specialist, the more options you have.
Q: Will losing weight on a GLP-1 drug fix my varicose veins?
A: Weight loss can reduce leg swelling and discomfort and may slow disease progression, but it does not correct the valve damage that causes varicose veins. That structural problem requires treatment. Less commonly discussed is that timing matters — CVR research shows that outcomes after vein procedures are meaningfully better in patients with lower BMI, suggesting that GLP-1-driven weight loss before treatment may improve what your specialist can achieve for you.
Q: My varicose veins look worse since I started Ozempic. Should I be worried?
A: Not necessarily. As fat under the skin diminishes, previously hidden veins become more visible — the disease has not necessarily progressed; the veins were already there. However, if new leg pain, swelling, or skin changes accompany the change in appearance, see a vein doctor for an ultrasound evaluation to confirm what is actually happening.
Q: Can GLP-1 medications cause blood clots?
A: The evidence is mixed. Some analyses show a reduced risk of pulmonary embolism with GLP-1 use, while one 2025 meta-analysis found a significantly higher DVT risk in patients who had been on these medications for more than 78 weeks. Early in treatment, dehydration due to nausea and reduced fluid intake can also temporarily increase the risk of clotting. If you experience sudden leg pain, redness, or swelling in one leg, seek medical attention promptly.
Q: Do I need to see a vein specialist before starting a GLP-1 medication?
A: If you have a history of varicose veins, leg swelling, DVT, or spend significant time sitting or standing at work, a vein evaluation before starting is clinically prudent. Identifying and treating existing vein problems in advance can help you avoid complications as rapid weight loss begins. For patients with suspected DVT, CVR offers same-day rule-out evaluation. Call our hotline number at 877-SCAN-DVT (877-722-6388).
Q: What type of exercise is best for my veins while taking GLP-1 medications
A: Resistance training is the priority. GLP-1 medications can cause muscle loss alongside fat loss, and the calf muscles specifically power the venous pump that returns blood from your legs to your heart. Preserving that muscle with regular strength work directly protects your venous circulation. Walking, swimming, and cycling are excellent complements — the goal is consistent movement that keeps the calf pump active throughout the day.
About Vein Disease
Spider Veins
Varicose Veins
Vein Disease Treatments
Treating Spider Veins
Treating Varicose Veins
About Us
Patient Resources
Physician Resources